Zacks Research Has Pessimistic View of Avantor Q1 Earnings

Avantor, Inc. (NYSE:AVTR) – Research analysts at Zacks Research reduced their Q1 2026 earnings per share (EPS) estimates for Avantor in a report issued on Tuesday, December 10th. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.30 per share for the quarter, down from their prior forecast of $0.32. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Avantor’s Q3 2026 earnings at $0.31 EPS and FY2026 earnings at $1.26 EPS.

AVTR has been the subject of several other reports. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Robert W. Baird lowered their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Barclays reduced their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Wells Fargo & Company lowered their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Finally, UBS Group decreased their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $27.69.

Avantor Stock Down 0.6 %

Shares of Avantor stock opened at $22.53 on Thursday. The firm has a market cap of $15.33 billion, a price-to-earnings ratio of 48.98, a P/E/G ratio of 2.59 and a beta of 1.29. The stock has a 50-day simple moving average of $22.59 and a 200-day simple moving average of $23.55. Avantor has a 52-week low of $19.59 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Institutional Trading of Avantor

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Sound Shore Management Inc. CT acquired a new stake in Avantor during the second quarter valued at approximately $76,412,000. Seven Eight Capital LP bought a new position in shares of Avantor during the 2nd quarter worth approximately $642,000. New York State Teachers Retirement System acquired a new stake in Avantor in the 3rd quarter valued at $8,473,000. Allspring Global Investments Holdings LLC grew its position in Avantor by 35.1% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock valued at $24,547,000 after acquiring an additional 300,579 shares during the period. Finally, Simplify Asset Management Inc. raised its stake in Avantor by 67.4% during the third quarter. Simplify Asset Management Inc. now owns 84,678 shares of the company’s stock worth $2,191,000 after acquiring an additional 34,102 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.